MedPath

USANA MULTIMINERAL TABLETS - TAB

USANA MULTIMINERAL TABLETS - TAB

Discontinued
DIN Number

02225751

Drug Class

Human

Market Date

Feb 17, 1997

Company
HC

usana health sciences inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02225751
AIG Number0928703001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification88:29.00*
Health Canada Classification

ACTIVE INGREDIENTS (9)

CALCIUM (CALCIUM CITRATE)Active
Strength: 90 MG / TAB
Monograph: CALCIUM (CALCIUM CITRATE)
CHROMIUM (CHROMIUM HVP CHELATE)Active
Strength: 100 MCG / TAB
Monograph: CHROMIUM (CHROMIUM HVP CHELATE)
COPPER (COPPER HVP CHELATE)Active
Strength: 1 MG / TAB
Monograph: COPPER (COPPER HVP CHELATE)
IODINE (POTASSIUM IODIDE)Active
Strength: .075 MG / TAB
Monograph: IODINE (POTASSIUM IODIDE)
MAGNESIUM (MAGNESIUM HVP CHELATE)Active
Strength: 100 MG / TAB
Monograph: MAGNESIUM (MAGNESIUM HVP CHELATE)
MANGANESE (MANGANESE HVP CHELATE)Active
Strength: 1.7 MG / TAB
Monograph: MANGANESE (MANGANESE HVP CHELATE)
MOLYBDENUM (MOLYBDENUM HVP CHELATE)Active
Strength: 16 MCG / TAB
Monograph: MOLYBDENUM (MOLYBDENUM HVP CHELATE)
SELENIUM (SELENIUM HVP CHELATE)Active
Strength: 66 MCG / TAB
Monograph: SELENIUM (SELENIUM HVP CHELATE)
ZINC (ZINC CITRATE)Active
Strength: 15 MG / TAB
Monograph: ZINC (ZINC CITRATE)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.